Myasthenia gravis (MG) is a rare nerve-muscle disease characterized by muscle weakness and exhaustion. It occurs when the communication between the brain and muscle tissue is broken. This breakdown is typically due to immune factors attacking the meeting place where nerve fibers and muscle fibers meet – the neuromuscular connection. Consequently,

Ketoconazole is a leading antifungal compound. This potent treatment effectively targets a wide range of fungal infections, positioning it a crucial resource in the fight against these detrimental conditions. Its capacity to inhibit ergosterol biosynthesis, a essential component of fungal cell membranes, results in significant impairment of fungal